GW433908 open label study for subjects with HIV who are treatment experienced, on a failing regimen or intolerant to current therapy and sensitive to GW433908
Latest Information Update: 23 Aug 2023
At a glance
- Drugs Fosamprenavir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 05 Sep 2006 New trial record.